Logo image of HNVR

HANOVER BANCORP INC/NY (HNVR) Stock Fundamental Analysis

NASDAQ:HNVR - Nasdaq - US4107102067 - Common Stock

24.61  -0.03 (-0.12%)

Fundamental Rating

2

Overall HNVR gets a fundamental rating of 2 out of 10. We evaluated HNVR against 405 industry peers in the Banks industry. HNVR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HNVR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HNVR was profitable.
HNVR had a positive operating cash flow in the past year.
HNVR Yearly Net Income VS EBIT VS OCF VS FCFHNVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 5M 10M 15M 20M 25M

1.2 Ratios

HNVR has a worse Return On Assets (0.51%) than 71.86% of its industry peers.
HNVR's Return On Equity of 6.21% is on the low side compared to the rest of the industry. HNVR is outperformed by 65.08% of its industry peers.
Industry RankSector Rank
ROA 0.51%
ROE 6.21%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNVR Yearly ROA, ROE, ROICHNVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2 4 6 8 10

1.3 Margins

The Profit Margin of HNVR (18.21%) is worse than 65.58% of its industry peers.
HNVR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 18.21%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNVR Yearly Profit, Operating, Gross MarginsHNVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

HNVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
HNVR has less shares outstanding than it did 1 year ago.
The debt/assets ratio for HNVR has been reduced compared to a year ago.
HNVR Yearly Shares OutstandingHNVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M
HNVR Yearly Total Debt VS Total AssetsHNVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

There is no outstanding debt for HNVR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 24.23
Altman-Z N/A
ROIC/WACCN/A
WACC16.42%
HNVR Yearly LT Debt VS Equity VS FCFHNVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 50M 100M 150M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HNVR Yearly Current Assets VS Current LiabilitesHNVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

HNVR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.05%.
HNVR shows a decrease in Revenue. In the last year, the revenue decreased by -9.68%.
EPS 1Y (TTM)-18.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)-9.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

HNVR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.79% yearly.
HNVR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.62% yearly.
EPS Next Y-19.64%
EPS Next 2Y8.25%
EPS Next 3Y15.79%
EPS Next 5YN/A
Revenue Next Year-14.65%
Revenue Next 2Y-0.52%
Revenue Next 3Y4.62%
Revenue Next 5YN/A

3.3 Evolution

HNVR Yearly Revenue VS EstimatesHNVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
HNVR Yearly EPS VS EstimatesHNVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.65 indicates a correct valuation of HNVR.
HNVR's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 28.29. HNVR is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 10.25, the valuation of HNVR can be described as reasonable.
Based on the Price/Forward Earnings ratio, HNVR is valued a bit cheaper than the industry average as 72.86% of the companies are valued more expensively.
HNVR is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.65
Fwd PE 10.25
HNVR Price Earnings VS Forward Price EarningsHNVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HNVR is valued more expensive than 82.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 172.85
EV/EBITDA N/A
HNVR Per share dataHNVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

HNVR's earnings are expected to grow with 15.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.25%
EPS Next 3Y15.79%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.67%, HNVR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.22, HNVR is paying slightly less dividend.
HNVR's Dividend Yield is slightly below the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

HNVR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
HNVR Yearly Dividends per shareHNVR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

18.73% of the earnings are spent on dividend by HNVR. This is a low number and sustainable payout ratio.
DP18.73%
EPS Next 2Y8.25%
EPS Next 3Y15.79%
HNVR Yearly Income VS Free CF VS DividendHNVR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 5M 10M 15M 20M
HNVR Dividend Payout.HNVR Dividend Payout, showing the Payout Ratio.HNVR Dividend Payout.PayoutRetained Earnings

More info and screens

HANOVER BANCORP INC/NY

NASDAQ:HNVR (1/22/2025, 10:28:31 AM)

24.61

-0.03 (-0.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-23 2024-10-23/amc
Earnings (Next)N/A N/A
Inst Owners15.11%
Inst Owner Change0%
Ins Owners24.63%
Ins Owner Change1.67%
Market Cap175.96M
Analysts80
Price Target26.01 (5.69%)
Short Float %1.21%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.41
Dividend Growth(5Y)N/A
DP18.73%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-34.05%
Min EPS beat(2)-77.53%
Max EPS beat(2)9.44%
EPS beat(4)3
Avg EPS beat(4)-4.5%
Min EPS beat(4)-77.53%
Max EPS beat(4)28.93%
EPS beat(8)5
Avg EPS beat(8)-4.76%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.15%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)-1.24%
Revenue beat(4)0
Avg Revenue beat(4)-4.01%
Min Revenue beat(4)-7.83%
Max Revenue beat(4)-1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.91%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.33%
PT rev (3m)30.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.43%
EPS NY rev (1m)0%
EPS NY rev (3m)3.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.33%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE 14.65
Fwd PE 10.25
P/S 2.72
P/FCF 172.85
P/OCF 57.02
P/B 0.93
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)1.68
EY6.83%
EPS(NY)2.4
Fwd EY9.76%
FCF(TTM)0.14
FCFY0.58%
OCF(TTM)0.43
OCFY1.75%
SpS9.06
BVpS26.58
TBVpS23.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 6.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 18.21%
GM N/A
FCFM 1.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 24.23
Debt/EBITDA N/A
Cap/Depr 124.5%
Cap/Sales 3.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 8.63%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC16.42%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y-19.64%
EPS Next 2Y8.25%
EPS Next 3Y15.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-14.65%
Revenue Next 2Y-0.52%
Revenue Next 3Y4.62%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.52%
OCF growth 3YN/A
OCF growth 5YN/A